Clinical trials
Peripheral Neuropathy With Type 2 Diabetes clinical trials
Below are recruiting peripheral neuropathy with type 2 diabetes clinical trials, each written for real people, not researchers. We’re tracking 71 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07285018RecruitingPhase 2
Study of a new drug for diabetic nerve pain in legs
This trial tests an investigational drug for people with pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It may help reduce pain in your lower legs if other treatments haven't worked well.
Birmingham, AlabamaAges 18 years+ - NCT07122726Recruiting
Balance exercises for fall prevention in diabetes
This study tests whether adding special movement exercises (called proprioceptive neuromuscular facilitation) to standard Otago exercises can help improve balance and reduce the risk of falls in people with type 2 diabetes who have nerve damage in their feet.
IslamabadAges 50–75 - NCT05203640Recruiting
Strength exercise study for post-menopausal type 1 diabetes
This study checks whether a resistance (strength) exercise program changes blood sugar levels in post-menopausal women with type 1 diabetes. You may be asked to do supervised lab-based exercise sessions near the University of Alberta.
Edmonton, AlbertaAges 45–75 - NCT05653518Recruiting
Artificial pancreas therapy to steady sugars and protect the heart
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
Charlottesville, VirginiaAges 18–40 - NCT05478707RecruitingPhase 2
Treating small blood vessel problems in type 1 diabetes
This study tests whether two different treatment strategies can improve the function of the tiny blood vessels in people with type 1 diabetes. It aims to find a way to prevent or reduce diabetes-related complications.
Orlando, FloridaAges 18–40 - NCT05188027Recruiting
Exercise types for postmenopausal women with type 1 diabetes
This study compares aerobic exercise (like brisk walking) versus resistance exercise (like strength training) to see which works better for women with type 1 diabetes after menopause. It may help you learn which exercise approach is safest and most helpful for blood sugar and health.
Edmonton, AlbertaAges 45–75 - NCT07144696Recruiting
Study to improve metabolic health in type 1 diabetes
This study offers a structured education course and regular checkups to help adults with type 1 diabetes better manage their blood sugar and overall health. Participants will learn about their condition and receive support to improve metabolic indicators.
BeijingAges 18 years+ - NCT06430814Recruiting
Blood test to predict nerve damage from paclitaxel
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
OdenseAges 18 years+ - NCT07518407Recruiting
Nutrition Education and Diet Guidance While Using GLP-1 Medication
This study teaches adults on GLP-1 medication (like Ozempic or Wegovy) how to eat better and lose weight using a smartphone app. Researchers want to see if personalized nutrition advice helps you get better results from your medication.
Columbia, South CarolinaAges 18–65 - NCT07477067Recruiting
Exercise and Protein Use in Type 2 Diabetes
This study looks at how exercise and protein work together in people aged 65 and older, either with or without type 2 diabetes. You will be asked to exercise and may receive a protein supplement to see how your body uses protein.
Urbana, IllinoisAges 65 years+ - NCT05354947Recruiting
Ultrasound test in adults with type 2 diabetes
This study tests whether a series of ultrasound treatments can improve blood sugar control in people with type 2 diabetes. You may be asked to stay on your current diabetes pills and avoid certain other medicines during the study.
New Haven, ConnecticutAges 21–75 - NCT06914557RecruitingPhase 2
Scrambler therapy plus duloxetine for chemo nerve pain
This study tests whether adding a non-invasive device called Scrambler Therapy to the usual nerve pain medicine (duloxetine) can better relieve chemotherapy-induced nerve pain. It is for people with cancer who still have significant nerve pain despite taking duloxetine.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06748963Recruiting
Fasted exercise training for type 1 diabetes
This study tests if exercising before breakfast (while fasting) helps improve blood sugar control and heart health in people with type 1 diabetes. You'll continue using your insulin pump and glucose monitor, and attend supervised exercise sessions and MRI scans to measure changes in your body.
Edmonton, AlbertaAges 18–55 - NCT06737926Recruiting
Balance exercises for chemotherapy nerve damage in breast cancer
This study tests whether special balance and coordination exercises can help reduce nerve damage side effects (like numbness or tingling) caused by chemotherapy in breast cancer patients. You may benefit if you have these symptoms and want to improve your balance and movement.
Lahore, Punjab ProvinceAges 30–65 - NCT04687215Recruiting
Spinal cord stimulation for painful diabetic nerve pain
This trial studies whether a spinal cord stimulator can reduce pain from diabetic nerve damage in the legs. It focuses on people with long-lasting type 2 diabetes and significant, treatment-resistant pain.
Chicago, IllinoisAges 18 years+ - NCT07051564Recruiting
Cell injection study for type 1 diabetes
This trial tests a new cell injection (CNK-UT009) for adults with type 1 diabetes. The goal is to see if it can help manage blood sugar and reduce insulin needs.
Zibo, ShandongAges 18–65 - NCT06731894RecruitingPhase 2
Cannabis for nerve pain after chemotherapy in breast and colon cancer survivors
This trial tests whether a cannabis-based product can reduce nerve damage (neuropathy) caused by chemotherapy in people who have finished treatment for breast or colon cancer. It focuses on survivors who still have pain, numbness, or tingling in their hands or feet.
Duarte, CaliforniaAges 18 years+ - NCT05341141Recruiting
Cold therapy plus compression to prevent nerve damage from chemo
This trial tests whether using cold therapy (cryotherapy) together with compression can lower the chance of numbness, tingling, or pain in the hands and feet caused by chemotherapy. It may help people planning chemotherapy for breast cancer stay more comfortable and function better.
Beijing, Beijing MunicipalityAges 20–70 - NCT07413731Recruiting
Medication tapering with spinal cord stimulation
This trial tests how changing your pain medications while using a spinal cord stimulator affects your nervous system. It may help people with chronic lower back pain find the best way to manage their pain and reduce reliance on strong drugs.
WilrijkAges 18 years+ - NCT06452914Recruiting
Testing therapeutic socks for diabetic nerve pain
This study tests special socks with tiny electronic parts to see if they can reduce nerve pain, numbness, and tingling in people with diabetic neuropathy. If you have mild to moderate symptoms and are not taking new medications for it, you may be able to join.
Roswell, GeorgiaAges 18–79 - NCT07072468RecruitingPhase 2
Test of a gel for nerve pain after chemotherapy
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
London, UKAges 18–80 - NCT06361108RecruitingPhase 1
Spray study for diabetic nerve pain in feet
This study tests a new spray medication (YJ001) applied to the feet to see if it is safe and helps reduce pain in people with diabetic peripheral neuropathy. You may qualify if you have diabetes, stable blood sugar, and moderate to severe nerve pain in your feet.
Fredericksburg, TexasAges 18–80 - NCT07634770RecruitingPhase 1
Oral insulin study compared to injected insulin
This early-stage study tests whether a new oral (swallowed) form of insulin called SCD0503 works as well as regular injected insulin in men with type 1 diabetes. Researchers will also check how food affects how your body absorbs the oral insulin.
Neuss, North Rhine-WestphaliaAges 18–64
Hear when a new Peripheral Neuropathy With Type 2 Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for peripheral neuropathy with type 2 diabetes?
- Yes. Clin2 currently lists 71 recruiting peripheral neuropathy with type 2 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a peripheral neuropathy with type 2 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a peripheral neuropathy with type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.